Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elderly ACS antiplatelet study: low-dose prasugrel versus standard clopidogrel
2013-000631-27Phase 3Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of prasugrel and clopidogrel in acute coronary syndrome (ACS) and coronary arteriosclerosis (2 arms), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Started May 2013; status: completed.
02
Drugs
prasugrelclopidogrel
03
Conditions
acute coronary syndrome (ACS)coronary arteriosclerosis
Beyond the preview
Go deeper on 2013-000631-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000631-27.